Latest news
Emcure to double down on complex generics, biosimilars, ARVs, says COO Samit Mehta - Moneycontrol.comMoneycontrol.com · Mon, 10 Aug 2026 07:05:30 GMTBuzzing Stocks: Emcure Pharma gains 3% on USFDA EIR; PFC slips 3% after mixed Q1 earnings - Moneycontrol.comMoneycontrol.com · Mon, 10 Aug 2026 03:59:36 GMTEmcure Pharma Receives USFDA Establishment Inspection Report for Sanand Facility - Medical DialoguesMedical Dialogues · Sun, 09 Aug 2026 16:14:21 GMTEmcure Pharmaceuticals Q1 profit rises 36% at ₹292.5 crore - BusinessLineBusinessLine · Sun, 09 Aug 2026 05:05:09 GMTEarnings Beat: Emcure Pharmaceuticals Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - simplywall.stsimplywall.st · Sun, 09 Aug 2026 03:58:31 GMTEmcure Pharma receives USFDA EIR for Sanand facility; regulator classifies it as 'VAI'; here's what it means - CNBC TV18CNBC TV18 · Sat, 08 Aug 2026 08:11:51 GMTEmcure Pharma Q1 revenue rises 23% to Rs 2,580 crore - Indian Pharma PostIndian Pharma Post · Fri, 07 Aug 2026 02:37:07 GMTEmcure Pharma net profit up 36% at Rs 292 crore - The Economic TimesThe Economic Times · Thu, 06 Aug 2026 19:41:35 GMT